WealthSource Partners’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,326
Closed -$907K 539
2022
Q2
$907K Sell
4,326
-31
-0.7% -$6.6K 0.07% 204
2022
Q1
$1.06M Sell
4,357
-43
-1% -$10.4K 0.07% 209
2021
Q4
$1.15M Sell
4,400
-1,294
-23% -$336K 0.09% 168
2021
Q3
$1.5M Buy
5,694
+1,680
+42% +$459K 0.13% 128
2021
Q2
$990K Hold
4,014
0.09% 170
2021
Q1
$779K Sell
4,014
-27
-0.7% -$5.41K 0.08% 186
2020
Q4
$859K Sell
4,041
-330
-8% -$65.8K 0.1% 136
2020
Q3
$749K Sell
4,371
-53
-1% -$9.79K 0.1% 139
2020
Q2
$849K Buy
4,424
+15
+0.3% +$2.45K 0.12% 112
2020
Q1
$649K Sell
4,409
-359
-8% -$57.2K 0.1% 142
2019
Q4
$739K Buy
4,768
+8
+0.2% +$1.15K 0.1% 175
2019
Q3
$643K Sell
4,760
-290
-6% -$38K 0.1% 198
2019
Q2
$616K Sell
5,050
-65
-1% -$7.2K 0.1% 200
2019
Q1
$532K Sell
5,115
-75
-1% -$7.74K 0.12% 158
2018
Q4
$591K Sell
5,190
-150
-3% -$16.1K 0.17% 129
2018
Q3
$616K Sell
5,340
-1,790
-25% -$196K 0.16% 130
2018
Q2
$739K Sell
7,130
-95
-1% -$9.61K 0.21% 110
2018
Q1
$711K Buy
7,225
+55
+0.8% +$5.2K 0.22% 113
2017
Q4
$607K Buy
7,170
+20
+0.3% +$1.65K 0.19% 117
2017
Q3
$550K Buy
7,150
+1,080
+18% +$82.6K 0.18% 124
2017
Q2
$473K Sell
6,070
-2,160
-26% -$155K 0.16% 134
2017
Q1
$592K Buy
8,230
+1,045
+15% +$72.2K 0.22% 108
2016
Q4
$446K Sell
7,185
-1,145
-14% -$70.1K 0.19% 114
2016
Q3
$540K Sell
8,330
-100
-1% -$6.66K 0.2% 110
2016
Q2
$533K Buy
8,430
+740
+10% +$43.6K 0.2% 108
2016
Q1
$445K Buy
+7,690
New +$435K 0.18% 116

Other funds holding RMD

WealthSource Partners's RMD Position: Q3 2022 in Review

WealthSource Partners sold out of ResMed (RMD) in Q3 2022, closing a stake of 4,326 shares — an estimated $907K sold.

WealthSource Partners first reported a position in RMD in Q1 2016 and held it in 26 quarters. The position peaked at $1.5M in Q3 2021. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • WealthSource Partners reported no remaining ResMed position as of Q3 2022 after selling out during the quarter.
  • WealthSource Partners sold 4,326 ResMed shares in Q3 2022, an estimated $907K.
  • WealthSource Partners first reported a position in ResMed in Q1 2016 and held it in 26 quarters.
  • WealthSource Partners's ResMed position peaked at $1.5M in Q3 2021.
  • 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on WealthSource Partners's 13F filing for Q3 2022, filed 15 Nov 2022.